Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 11.45M $894.50M Sept. 30, 2014
Wellington Management Company 9.13M $576.88M June 30, 2014
Vanguard 3.58M $279.89M Sept. 30, 2014
T. Rowe Price Associates 3.25M $205.43M June 30, 2014
Franklin Resources 2.26M $176.65M Sept. 30, 2014
Gilder, Gagnon, Howe & Co 1.99M $155.23M Sept. 30, 2014
HealthCor Management 1.80M $16.87M June 30, 2011
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.72M $134.69M Sept. 30, 2014
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 1.59M $124.45M Sept. 30, 2014
BlackRock Fund Advisors 1.47M $114.52M Sept. 30, 2014
HealthCor Management 1.45M $35.34M March 31, 2013
Bridger Management 1.37M $33.31M March 31, 2013
Deerfield Management Company 1.22M $29.77M March 31, 2013
BAILLIE GIFFORD & CO 1.19M $93.01M Sept. 30, 2014
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
Jennison Associates 1.13M $88.11M Sept. 30, 2014
Abingworth 1.11M $20.29M Dec. 31, 2012
STATE STREET CORPORATION 1.11M $86.60M Sept. 30, 2014
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
LORD, ABBETT & CO 1.03M $31.83M June 30, 2013
Wells Fargo & Company 1.01M $63.79M June 30, 2014
Columbus Circle Investors 1.00M $67.43M March 31, 2014
Falcon Edge Capital 1000000 $64.30M Dec. 31, 2013
Camber Capital Management 1000000 $31.01M June 30, 2013
Columbia Wanger Asset Management 902764 $60.61M March 31, 2014
MORGAN STANLEY 861835 $67.31M Sept. 30, 2014
Capital World Investors^ 848700 $53.61M June 30, 2014